New imaging agent aims to spot hidden cancers
NCT ID NCT07432633
First seen Feb 28, 2026 · Last updated May 11, 2026 · Updated 6 times
Summary
This study tests a new imaging agent called [18F]FPyQCP for PET scans to detect five types of cancer: colorectal, ovarian, gastric, invasive lobular breast, and pancreatic. About 71 adults will receive a single dose of the agent to check its safety and how well it finds cancer, especially in the abdomen. The goal is to improve cancer detection without direct treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Texas Southwestern Medical Center
RECRUITINGDallas, Texas, 75390, United States
Contact
Conditions
Explore the condition pages connected to this study.